ISOPP: Submit your Abstract(s) by October 20th!

Get your research out there – submit your abstract now!

With all the impressive research underway in oncology pharmacy, and by request, the deadline to submit an abstract for XXI International Symposium on Oncology Pharmacy Practice (ISOPP 2023) has been extended to Thursday, October 20, 2022 at 11:59pm UTC!

 

Submit your Abstract(s) here

 

View submission information and guidelines on the ISOPP 2023 website. Click on the links below to go directly to any of the following sections:

·     How to write an Abstract

·     Submit Your Abstract(s)

·     Abstract Submission Guidelines

·     Platform Presentation Information

·     Poster Award

·     Questions

 

If you have any questions regarding the abstract submission system or any difficulties submitting your abstract, please contact the abstract manager at [email protected]

 

ISOPP 2023 takes place March 2 to 4, 2023, followed by one day Masterclasses on March 5, at the Barceló Sevilla Renacimiento in Seville, Spain. The national hosts are Grupo de Farmacia Oncológica y Hematológica de la SEFH (GEDEFO) Oncology Working Group of Sociedad Espanola de Farmacia Hospitalaria (SEFH).

 

Visit the ISOPP 2023 website for more information and Program at a Glance for Symposium updates as they are made available. Spread the word using #ISOPP2023 and please forward this notice to your friends and colleagues who may be interested in what the Symposium has to offer and encourage them to join ISOPP’s mailing list.

 

We look forward to receiving your abstracts and seeing you in Seville in March 2023!

 

Yours sincerely

ISOPP

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article